Article
Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
Human genomics - 19 Jul 2024
Heczko Lucie, Liška Václav, Vyčítal Ondřej, Fiala Ondřej, Šůsová Simona, Hlaváč Viktor, Souček Pavel
Abstract excerpt
BACKGROUND: Colorectal cancer is still the second leading cause of cancer-related deaths and thus biomarkers allowing prediction of the resistance of patients to therapy and estimating their prognosis are needed. We designed a panel of 558 genes with pharmacogenomics records related to 5-fluorouracil resistance, genes important for sensitivity to other frequently used drugs, major oncodrivers, and actionable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
